In this comprehensive guide, we examine key disruptions of 2024, analyze what worked—and what failed—in pharma supply chain responses, and outline strategic actions leaders must take in 2025 to thrive amid uncertainty.
The Future of Digital Supply Chain Standards: How Will Interoperability Shape Pharma Supply Chains?
As the industry leans into digital transformation, achieving interoperability—the seamless interaction between diverse systems—has become a primary goal.
How to Transition to a Fully Digital Supply Chain by 2025: A Roadmap
The supply chain industry is rapidly evolving, with digital transformation reshaping traditional practices. For organizations, particularly in sectors like the pharma supply chain, transitioning to a fully digital supply chain by 2025 is not just an option—it’s a necessity. This article outlines a clear roadmap to help businesses modernize their...
From Compliance to Competitive Edge: Leveraging 2025’s Traceability Mandates in Pharma Supply Chains
This in‑depth guide explains why the 2025 deadlines—particularly DSCSA’s interoperable data exchange requirement—represent a watershed moment for the pharma supply chain.
Partnering for Resilience: How New Alliances Are Strengthening Pharma Supply Chains in 2025
Little wonder that 37% of life science executives now identify building “resilient and adaptable supply chains” as a top priority entering 2025. The key to this resilience? Increasingly, it’s strategic partnerships.
